207 related articles for article (PubMed ID: 23983160)
1. Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study.
Connor JT; Luce BR; Broglio KR; Ishak KJ; Mullins CD; Vanness DJ; Fleurence R; Saunders E; Davis BR
Clin Trials; 2013 Oct; 10(5):807-27. PubMed ID: 23983160
[TBL] [Abstract][Full Text] [Related]
2. Using Bayesian Adaptive Trial Designs for Comparative Effectiveness Research: A Virtual Trial Execution.
Luce BR; Connor JT; Broglio KR; Mullins CD; Ishak KJ; Saunders E; Davis BR;
Ann Intern Med; 2016 Sep; 165(6):431-8. PubMed ID: 27273013
[TBL] [Abstract][Full Text] [Related]
3. Bayesian adaptive designs for multi-arm trials: an orthopaedic case study.
Ryan EG; Lamb SE; Williamson E; Gates S
Trials; 2020 Jan; 21(1):83. PubMed ID: 31937341
[TBL] [Abstract][Full Text] [Related]
4. Adaptive Bayesian randomized trials: realizing their potential.
Pullenayegum EM
J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():29-33. PubMed ID: 22810444
[TBL] [Abstract][Full Text] [Related]
5. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus.
Connor JT; Elm JJ; Broglio KR;
J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S130-7. PubMed ID: 23849147
[TBL] [Abstract][Full Text] [Related]
6. Using Bayesian adaptive designs to improve phase III trials: a respiratory care example.
Ryan EG; Bruce J; Metcalfe AJ; Stallard N; Lamb SE; Viele K; Young D; Gates S
BMC Med Res Methodol; 2019 May; 19(1):99. PubMed ID: 31088354
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.
Brown AR; Gajewski BJ; Aaronson LS; Mudaranthakam DP; Hunt SL; Berry SM; Quintana M; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Barohn RJ
Trials; 2016 Aug; 17(1):428. PubMed ID: 27577191
[TBL] [Abstract][Full Text] [Related]
8. Point-of-Care Clinical Trials in Sports Medicine Research: Identifying Effective Treatment Interventions Through Comparative Effectiveness Research.
Lam KC; Bacon CEW; Sauers EL; Bay RC
J Athl Train; 2020 Mar; 55(3):217-228. PubMed ID: 31618071
[TBL] [Abstract][Full Text] [Related]
9. Bayesian adaptive randomization designs for targeted agent development.
Lee JJ; Xuemin Gu ; Suyu Liu
Clin Trials; 2010 Oct; 7(5):584-96. PubMed ID: 20571130
[TBL] [Abstract][Full Text] [Related]
10. A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.
Cunanan KM; Carlin BP; Peterson KA
Clin Trials; 2016 Dec; 13(6):641-650. PubMed ID: 27430710
[TBL] [Abstract][Full Text] [Related]
11. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
Ryan EG; Brock K; Gates S; Slade D
BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
[TBL] [Abstract][Full Text] [Related]
12. Innovative designs of point-of-care comparative effectiveness trials.
Shih MC; Turakhia M; Lai TL
Contemp Clin Trials; 2015 Nov; 45(Pt A):61-8. PubMed ID: 26099528
[TBL] [Abstract][Full Text] [Related]
13. Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research.
Duan N; Kravitz RL; Schmid CH
J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S21-8. PubMed ID: 23849149
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian decision-theoretic sequential response-adaptive randomization design.
Jiang F; Jack Lee J; Müller P
Stat Med; 2013 May; 32(12):1975-94. PubMed ID: 23315678
[TBL] [Abstract][Full Text] [Related]
15. A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials.
Wason JM; Trippa L
Stat Med; 2014 Jun; 33(13):2206-21. PubMed ID: 24421053
[TBL] [Abstract][Full Text] [Related]
16. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
Mullins CD; Sanchez RJ
J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
[TBL] [Abstract][Full Text] [Related]
17. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
Yu Q; Zhu L; Zhu H
Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
[TBL] [Abstract][Full Text] [Related]
18. Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Pressel S; Davis BR; Louis GT; Whelton P; Adrogue H; Egan D; Farber M; Payne G; Probstfield J; Ward H;
Control Clin Trials; 2001 Dec; 22(6):674-86. PubMed ID: 11738123
[TBL] [Abstract][Full Text] [Related]
19. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
Thall P; Fox P; Wathen J
Ann Oncol; 2015 Aug; 26(8):1621-8. PubMed ID: 25979922
[TBL] [Abstract][Full Text] [Related]
20. Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine.
Zhou X; Liu S; Kim ES; Herbst RS; Lee JJ
Clin Trials; 2008; 5(3):181-93. PubMed ID: 18559407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
